The Incidence of Melanoma in the East Bohemian Region in the Period 1996–2017

Czech version

Authors: J. Čelakovská ¹; J. Bukač ²; M. Šimková ¹; E. Jandová ¹
Authors‘ workplace: Klinika nemocí kožních a pohlavních FN a LF UK Hradec Králové, přednosta doc. MUDr. Milosav Salavec, CSc. ¹; Ústav lékařské biofyziky LF UK Hradec Králové, přednosta doc. Ing. Josef Hanuš, CSc. ²
Published in: Čes-slov Derm, 95, 2020, No. 2, p. 57-68
Category: Pharmacologyand Therapy, Clinical Trials

Overview

Objectives: To evaluate the incidence of melanoma and some of its characteristics (including histology, localization, duration) in the period 1996–2017 in Eastern Bohemia in the Czech Republic. Another goal was to assess whether the number of hours of sunshine per year can affect the frequency of melanoma.

Method: In the period 1996–2017, the diagnosis of melanoma was established in 2810 patients examined in the outpatient clinic for dark tumors at the Department of Dermatology in Hradec Králové. We evaluated the incidence of melanoma in men and women, age, histology, localisation and time period to diagnosis of melanoma.

Results and conclusion: There was no statistical difference in the incidence of melanoma between men and women. Significant differences between men and women were noted in the localization of melanoma and the duration of the lesion. In women, melanoma was significantly more frequently found in the lower and upper limbs, in men on the trunk. We did not confirm the relationship between the duration of melanoma and histology. We have shown a significant correlation between histology and melanoma localization, between the duration of the lesion and melanoma localization. Pigmented nevi that have been present since childhood developed melanoma in 24% of patients, significantly more frequently on the torso than on the face. The increasing incidence of melanoma on the trunk duration of previous lesions was confirmed. We have not confirmed the relationship between the annual number of hours of sunshine and the incidence of melanomas.

Keywords:

melanoma – histology – localization of melanoma – pigment nevi – length of sunshine

Sources

1. ARMSTRONG, B. K., CUST, A. E. Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: a perspective on Fears et al. mathematical models of age and ultraviolet effects on the incidence of skin can-cer among whites in the United States. Cancer Epidemiol, 2017,48, p.147–156.

2. AUSTRALIAN BUREAU OF STATISTICS. (2012). 3303.0. – Causes of death, Australia 2010: Underlying causes of death. Canberra, Australia: ABS. Dostupné na www: www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3303.02010.

3. AUTIER, P., DORE, J. F., GEFELLER, O. et al. Melanoma risk and residence in sunny areas. EORTC Melanoma Co‐operative Group. European Organization for Research and Treatment of Cancer. Br. J. Cancer, 1997, 76, p. 1521–1524.

4. BARYSCH, M. J., LEVESQUE, M. P., CHENG, P., KARPOVA, M. B., MIHIC-PROBST, D., CIVENNI, G. et al. Coexpression of SOX10/CD271 (p75(NTR)) and beta-galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology (Basel), 2014,1(1), p. 35–46.

5. BERG, S. A., MING, M. E. Recent Advances in Our Understanding of the Epidemiology of Melanoma. Curr Derm Rep, 2017, 6(3), p. 211–221.

6. BEVONA, C., FEWKES, J., LIU, V., SOBER, A. J. Prolonged evolution of a LM. J Am Acad Dermatol, 2004, 51(5), p. 830–835.

7. BEVONA, C., GOGGINS, W., QUINN, T., FULLERTON, J., TSAO, H. Cutaneous melanomas associated with nevi. Arch Dermatol, 2003,139(12), p. 1620–1624.

8. CAINI, S., GANDINI, S., SERA, F. et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clino-pathological variant. Eur J Cancer, 2009, 45, p. 3054–3063.

9. CALIFANO, J., NANCE, M. Malignant melanoma. Facial Plast Surg Clin North Am, 2009, 17(3), p. 337–348.

10. CANCER COUNCIL ACT. Skin cancer in Australia. 2017. Dostupné na www: www.actcancer.org/prevention/sunsmart/skin-cancer-in-Australia.

11. COCKBURN, M., SWETTER, S. M., PENG, D., KEEGAN, T. H., DEAPEN, D., CLARKE, C. A. Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? J Am Acad Dermatol, 2008, 59, p. 1081–1085.

12. COLANTONIO, S., BRACKEN, M. B., BEECKER, J. The association of indoor tanning and melanoma in adults: systematic review and meta-analysis. J Am Acad Dermatol, 2014, 70(5), p. 847–857. e1–18.

13. COURTENAY, W. H. Constructions of masculinity and their influence on men‘s well-being: a theory of gender and health. Soc Sci Med, 2000, 50(10), p. 1385–1401.

14. DAL, H., BOLDEMANN, C., LINDELÖF, B. Does relative melanoma distribution by body site 1960–2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? Eur J Dermatol, 2007, 17(5), p. 428–434.

15. DEMIERRE, M. F., CHUNG, C., MILLER, D. R., GELLER, A. C. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol, 2005, 141(6), p. 745–750.

16. DENNIS, L. K. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol, 1999, 135, p. 275–280.

17. D‘ORAZIO, J., JARRETT, S., AMARO-ORTIZ, A., SCOTT, T. UV radiation and the skin. Int J Mol Sci, 2013,14(6), p.12222–12248.

18. ERDEI, E., TORRES, S. M. A new understanding in the epidemiology of melanoma. Exp Rev Anticancer Ther, 2010, 10(11), p. 1811–1823.

19. ETTLER, K. Fotobiologické aspekty maligního melanomu (Klinická studie.). Supplementum Sborníku vědeckých prací Lékařské fakulty UK v Hradci Králové, 1992, 35(4), p. 324–343.

20. FILIPPI, A. R., FAVA, P., BADELLINO, S., ASTRUA, C., RICARDI, U., QUAGLINO, P. Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol, 2016, 120(1), p.1–12.

21. GANDINI, S., SERA, F., CATTARUZZA, M. S. et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer, 2005, 41, p. 45–60.

22. GARBE, C., LEITER, U. Melanoma epidemiology and trends. Clin Dermatol, 2009, 27, p. 3–9.

23. GHIASVAND, R., ROBSAHM, T. E., GREEN, A. C., RUEEGG, C. S., WEIDERPASS, E., LUND, E., VEIERØD, M. B. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites. JAMA Dermatol, 2018, Nov 21. doi: 10.1001/jamadermatol.2018.3964. [Epub ahead of print].

24. GIBLIN, A. V., THOMAS, J. M. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthet Surg, 2007, 60, p. 32–40.

25. GIMOTTY, P. A., SHORE, R., LOZON, N. L. et al. Miscoding of melanoma thickness in SEER: research and clinical implications. J Invest Dermatol, 2016, 136, p. 2168–2172.

26. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase, 2013, 11. Dostupné na www: http://globocan.iarc.fr.

27. GOODSON, A. G., GROSSMAN, D. Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol, 2009, 60(5), p.719–735. quiz 36–38.

28. GUY, G. P. jr., THOMAS, C. C., THOMPSON, T., WATSON, M., MASSETTI, G. M. RICHARDSON, L. C. Vital signs: Melanoma incidence and mortality trends and projections – United States, 1982–2030. MMWR Morb Mortal Wkly Rep, 2015, 64(21), p. 591–596.

29. HAENSSLE, H. A., MOGRABY, N., NGASSA, A., BUHL, T., EMMERT, S., SCHON, M. P. et al. Association of patient risk factors and frequency of nevus-associated cutaneous melanomas. JAMA Dermatol, 2016,152(3), p. 291–298.

30. HALL, H. I., JAMISON, P., FULTON, J. P., CLUTTER, G., ROFFERS, S., PARRISH, P. Reporting cutaneous melanoma to cancer registries in the United States. J Am Acad Dermatol, 2003, 49, p. 624–630.

31. HILLHOUSE, J., TURRISI, R., STAPLETON, J., ROBINSON, J. A randomized controlled trial of an appearance‐focused intervention to prevent skin can-cer. Cancer, 2008, 113(11), p. 3059–3274.

32. HOWLADER, N., NOONE, A. M., KRAPCHO, M., MILLER, D., BISHOP, K., KOSARY, C. L., YU, M., RUHL, J., TATALOVICH, Z., MARIOTTO, A., LEWIS, D. R., CHEN, H. S., FEUER, E. J., CRONIN, K. A. (eds). SEER cancer statistics review, 1975–2014, National Cancer Institute. Bethesda, MD. Dostupné na www: http://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.

33. JACKSON, K., AIKEN, L. A psychosocial model of sun protection and sunbathing in young women: The impact of health beliefs, attitudes, norms and self‐efficacy for sun protection. Health Psychology, 2000, 19(5), p. 469–478.

34. JEMAL, A., SARAIYA, M., PATEL, P. et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol, 2011, 65 (5 suppl 1), p. 17–25.

35. JOHNSON-OBASEKI, S., LABAJIAN, V., CORSTEN, M. J., MCDONALD, J. Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992–2006. J Otolaryngol Head Neck Surg, 2015, 2(44), p. 53.

36. JOOSSE, A., COLLETTE, S., SUCIU, S., NIJSTEN, T., PATEL, P. M., KEILHOLZ, U. et al. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials. J Clin Oncol, 2013, 31(18), p. 2337–2346.

37. KOH, H. K., GELLER, A. C., MILLER, D. R., GROSSBART, T. A., LEW, R. A. Prevention and early detection strategies for melanoma and skin cancer. Current status Arch Dermatol, 1996, 132(4), p. 436–443.

38. KRENGEL, S., HAUSCHILD, A., SCHAFER, T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol, 2006,155(1), p.1–8.

39. KUBICA, A., BREWER, J. Melanoma in immunosuppressed patients. Mayo Clin Proc, 2012, 87(10), p. 991–1003.

40. LAZOVICH, D., VOGEL, R. I., BERWICK, M., WEINSTOCK, M. A., WARSHAW, E. M., ANDERSON, K. E. Melanoma risk in relation to use of sunscreen or other sun protection methods. Cancer Epidemiol Biomarkers Prev, 2011, 20, p. 2583–2593.

41. LINOS, E., SWETTER, S. M., COCKBURN, M. G., COLDITZ, G. A., CLARKE, C. A. Increasing burden of melanoma in the United States. J Investig Dermatol, 2009, 129(7), p. 1666–1674.

42. LINO-SILVA, L. S., DOMINGUEZ-RODRIGUEZ, J. A., AGUILAR-ROMERO, J. M., MARTINEZ-SAID, H., SALCEDO-HERNANDEZ, R. A., GARCIA-PEREZ, L. et al. Melanoma in Mexico: clinicopathologic features in a population with predominance of acral lentiginous subtype. Ann Surg Oncol, 2016, 23(13), p. 4189–4194.

43. LIU, F., BESSONOVA, L., TAYLOR, T. H., ZIOGAS, A., MEYSKENS, F. L., JR, ANTON-CULVER, H. A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma Res, 2013, 26(1), p. 128–135.

44. LIU-SMITH, F., FARHAT, A. M., ARCE, A., ZIOGAS, A., TAYLOR, T., WANG, Z., et al. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure. J Am Acad Dermatol, 2017, 76(3), p. 499–505.

45. LIU-SMITH, F., ZIOGAS, A. An age-dependent interaction between sex and geographical UV index in melanoma risk. J Am Acad Dermatol, 2017, pii: S0190-9622(17)32748-2. doi: 10.1016/j.jaad.2017.11.049., Epub ahead of print.

46. MOAN, J., DAHLBACK, A. The relationship between skin cancers, solar radiation and ozone depletion. Br J Cancer, 1992, p. 65:916–921.

47. MOHER, D., HOPEWELL, S., SCHULZ, K. F., MONTORI, V., GØTZSCHE, P. C., DEVEREAUX, P. J. et al. for the CONSORT Group. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trial. BMJ, 2010, 340, p. 869.

48. MOUNESSA, J. S , CARAVAGLIO, J. V, DELLAVALLE, R. P. Comparison of regional and state differences in melanoma rates in the United States: 2003 vs 2013. JAMA Dermatol, 2017, 153, p. 345–347.

49. OLSEN, C. M., ZENS, M. S., GREEN, A. C. et al. Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis. Int J Cancer, 2011, 129, p.713–723.

50. PAWLAK, M. T., BUI, M., AMIR, M., BURKHARDT, D. L., CHEN, A. K., DELLAVALLE, R. P. Legislation restricting access to indoor tanning throughout the world. Arch Dermatol, 2012, 148(9), p. 1006–1012.

51. PÉREZ-GÓMEZ, B., ARAGONÉS, N., GUSTAVSSON, P., LOPE, V., LÓPEZ-ABENTE, G., POLLÁN, M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br J Dermatol, 2008, 158(4), p. 766–772.

52. RASTRELLI, M., TROPEA, S., ROSSI, C., ALAIBAC, M. Melanoma, Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification. In vivo, 2014, 28 (6), p. 1005–1011.

53. SHAIKH, W. R., WEINSTOCK, M. A., HALPERN, A. C., OLIVERIA, S. A ., GELLER, A. C., DUSZA, S. W. The characterization and potential impact of melanoma cases with unknown thickness in the United States‘ Surveillance, Epidemiology, and End Results Program, 1989–2008. Cancer Epidemiol, 2013, 37, p. 64–70.

54. SHAIN, A. H., BASTIAN, B. C. From melanocytes to melanomas. Nat Rev Cancer, 2016, 16(6), p. 345–358.

55. SIEGEL, R. L., MILLER, K. D., JEMAL, A. Cancer statistics. 2017. CA Cancer J Clin, 2017,67(1), p. 7–30.

56. STANTON, W. R., JANDA, M., BAADE, P. D., ANDERSON, P. Primary prevention of skin cancer: A review of sun protection in Australia and internationally. Health Promotion International, 2004,19(3), p. 369–378.

57. Surveillance, epidemiology, and end results (seer). Program cancer statistics review, 1975–2013, National cancer institute [Internet] Nov, 2015. Seer data submission. Dostupné na www: http://seer.cancer.gov/csr/1975_2013.

58. SWERDLOW, A. J. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J, 1979, 24, 2(6201), p.1324–1327.

59. ŠTORK, J. et al. Dermatovenerologie. 2008. Galén, Karolinum. ISBN 978-80-7262-6, s. 393.

60. VAN DER LEEST, R., FLOHIL, S., ARENDS, L., DE VRIES, E., NIJSTEN, T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol, 2015, 29(6), p.1053–1062.

61. WATSON, M., JOHNSON, C. J., CHEN, V. W. et al. Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol, 2011, 65(5 suppl 1), p. 6–16.

62. WATTS, C. G., MADRONIO, C., MORTON, R. L., GOUMAS, C., ARMSTRONG, B. K., CURTIN, A. et al. Clinical features associated with individuals at higher risk of melanoma: a population-based study. JAMA Dermatol, 2017,153(1), p. 23–29.

63. WELCH, H. G.,WOLOSHIN, S., SCHWARTZ, L. M. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ, 2005, 331, p. 481.

64. WHITEMAN, D. C., PAVAN, W. J., BASTIAN, B. C. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res, 2011, 24(5), p. 879–897.

65. WHITEMAN, D. C., STICKLEY, M., WATT, P., HUGHES, M. C., DAVIS, M. B., GREEN, A. C. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol, 2006, 24(19), p. 3172–3177.

Labels

Dermatology & STDs Paediatric dermatology & STDs

Darier Disease: Current View. Part One.

Follicular Mucinosis. Case report

Pleomorphic Leiomyosarcoma. Case Report

Multiple cutaneous nodules. Minireview.

Zápis ze schůze výboru

Article was published in

Czech-Slovak Dermatology

2020 Issue 2